DWP
GILD icon

Destiny Wealth Partners’s Gilead Sciences GILD Stock Holding History

Destiny Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,105
Closed -$154K – 518
2026
Q1 		$154K Buy
+1,105
New +$155K 0.02% 262
2023
Q1 		– Sell
-142
Closed -$12.2K – 351
2022
Q4 		$12.2K Buy
+142
New +$11.2K ﹤0.01% 455
2022
Q3 		– Sell
-3,500
Closed -$216K – 592
2022
Q2 		$216K Buy
+3,500
New +$217K 0.05% 174
2022
Q1 		– Sell
-882
Closed -$64K – 569
2021
Q4 		$64K Buy
882
+56
+7% +$3.86K 0.01% 282
2021
Q3 		$58K Buy
+826
New +$58K 0.01% 261

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Destiny Wealth Partners's GILD Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,105 shares — an estimated $154K sold.

Destiny Wealth Partners first reported a position in GILD in Q3 2021 and held it in 5 quarters. The position peaked at $216K in Q2 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Destiny Wealth Partners reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Destiny Wealth Partners sold 1,105 Gilead Sciences shares in Q2 2026, an estimated $154K.
  • Destiny Wealth Partners first reported a position in Gilead Sciences in Q3 2021 and held it in 5 quarters.
  • Destiny Wealth Partners's Gilead Sciences position peaked at $216K in Q2 2022.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.